Literature DB >> 22885838

Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer.

Silke Schüle1, Yves Dittmar, Thomas Knösel, Peter Krieg, Roland Albrecht, Utz Settmacher, Annelore Altendorf-Hofmann.   

Abstract

BACKGROUND: Resection of colorectal liver or lung metastases is an established therapeutical concept at present. However, an affection of both these organs is frequently still regarded as incurable.
METHODS: All cancer patients are documented in our prospective cancer registry since 1995. Data of patients who underwent liver and lung resection for colorectal metastases were extracted and analysed.
RESULTS: Sixty-five patients underwent surgery for liver and lung metastases. In 33 cases, the first distant metastasis was diagnosed synchronously to the primary tumour. For the remaining patients, median time interval between primary tumour and first distant metastasis was 18 months (5-69 months). Complete resection was achieved in 51 patients (79 %) and was less likely in patients with synchronous disease (p = 0.017). Negative margins (p = 0.002), the absence of pulmonary involvement in synchronous metastases (p = 0.0003) and single metastases in both organs (p = 0.036) were associated with a better prognosis. Five- and 10-year survival rates for all patients are 57 and 15 % from diagnosis of the primary tumour, 37 and 14 % from resection of the first metastasis and 20 and 15 % from resection of the second metastasis. After complete resection, 5- and 10-year survival rates increased to 61 and 18 %, 43 and 17 % as well as 25 and 19 %, respectively. Long-term survivors (≥10 years) were seen only after complete resection of both metastases.
CONCLUSIONS: Patients with resectable liver and lung metastases of the colorectal primary should be considered for surgery after multidisciplinary evaluation regardless of the number or size of the metastases or the disease-free intervals. Clear resection margins are the strongest prognostic parameter.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885838     DOI: 10.1007/s00384-012-1553-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  25 in total

1.  Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.

Authors:  Vincenzo Valentini; Ruud G P M van Stiphout; Guido Lammering; Maria Antonietta Gambacorta; Maria Cristina Barba; Marek Bebenek; Franck Bonnetain; Jean-Francois Bosset; Krzysztof Bujko; Luca Cionini; Jean-Pierre Gerard; Claus Rödel; Aldo Sainato; Rolf Sauer; Bruce D Minsky; Laurence Collette; Philippe Lambin
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544

2.  Surgical treatment of hepatic and pulmonary metastases from colon cancer.

Authors:  J R Headrick; D L Miller; D M Nagorney; M S Allen; C Deschamps; V F Trastek; P C Pairolero
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

3.  Role of surgical resection in colorectal lung metastases: analysis of 137 patients.

Authors:  Piero Borasio; Mara Gisabella; Andrea Billé; Luisella Righi; Marina Longo; Marco Tampellini; Francesco Ardissone
Journal:  Int J Colorectal Dis       Date:  2010-10-20       Impact factor: 2.571

4.  Surgical management of pulmonary metastases from colorectal cancer in 153 patients.

Authors:  Süleyman Yedibela; Peter Klein; Karsta Feuchter; Martin Hoffmann; Thomas Meyer; Thomas Papadopoulos; Jonas Göhl; Werner Hohenberger
Journal:  Ann Surg Oncol       Date:  2006-09-29       Impact factor: 5.344

5.  Long-term outcome after sequential resections of liver and lung metastases from colorectal carcinoma.

Authors:  Ravi Marudanayagam; Krishnamoorthy Ramkumar; Vivekanandan Shanmugam; Gerald Langman; Pala Rajesh; Chris Coldham; Simon R Bramhall; David Mayer; John Buckels; Darius F Mirza
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

6.  Multiple resections for hepatic and pulmonary metastases of colorectal carcinoma.

Authors:  Shinichiro Takahashi; Kanji Nagai; Norio Saito; Masaru Konishi; Toshio Nakagohri; Naoto Gotohda; Mitsuyo Nishimura; Junji Yoshida; Taira Kinoshita
Journal:  Jpn J Clin Oncol       Date:  2007-03       Impact factor: 3.019

7.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

8.  Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.

Authors:  George Miller; Peter Biernacki; Nancy E Kemeny; Mithat Gonen; Robert Downey; William R Jarnagin; Michael D'Angelica; Yuman Fong; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2007-06-27       Impact factor: 6.113

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 10.  Oligometastases and oligo-recurrence: the new era of cancer therapy.

Authors:  Yuzuru Niibe; Kazushige Hayakawa
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019

View more
  18 in total

Review 1.  [Assessment of resectability of colorectal liver metastases and extended resection].

Authors:  U Settmacher; H Scheuerlein; F Rauchfuss
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

Review 2.  Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?

Authors:  Khurum Khan; Anita Wale; Gina Brown; Ian Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis.

Authors:  Mitsuhiro Kamiyoshihara; Hitoshi Igai; Natsuko Kawatani; Takashi Ibe; Naoki Tomizawa; Kai Obayashi; Kimihiro Shimizu; Izumi Takeyoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-02-08

4.  Indeterminate pulmonary nodules in colorectal cancer.

Authors:  Eun-Joo Jung; Su-Ran Kim; Chun-Geun Ryu; Jin Hee Paik; Jeong Geun Yi; Dae-Yong Hwang
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

5.  Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.

Authors:  Jocelyn Bellier; Julien De Wolf; Mohamed Hebbar; Mehdi El Amrani; Christophe Desauw; Emmanuelle Leteurtre; François-René Pruvot; Henri Porte; Stéphanie Truant
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

6.  Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases.

Authors:  Hiroaki Nozawa; Junichiro Tanaka; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Jun Nakajima; Norihiro Kokudo; Toshiaki Watanabe
Journal:  Mol Clin Oncol       Date:  2015-07-08

Review 7.  Thermal Ablation of Metastatic Colon Cancer to the Liver.

Authors:  Juan C Camacho; Elena N Petre; Constantinos T Sofocleous
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 8.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

9.  Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone.

Authors:  Georgios Meimarakis; Martin Angele; Claudius Conrad; Rolf Schauer; Rolf Weidenhagen; Alexander Crispin; Clemens Giessen; Gerhard Preissler; Max Wiedemann; Karl-Walter Jauch; Volker Heinemann; Sebastian Stintzing; Rudolf A Hatz; Hauke Winter
Journal:  Langenbecks Arch Surg       Date:  2013-01-13       Impact factor: 3.445

10.  Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.

Authors:  Jutao Feng; Junhua Cen; Jun Li; Rujin Zhao; Canhua Zhu; Zongxin Wang; Jiafen Xie; Wei Tang
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.